Long-term follow-up of a randomized trial of interferon therapy for chronic hepatitis B in a predominantly homosexual male population.

[1]  G. Fattovich,et al.  Long‐term outcome of hepatitis B e antigen–positive patients with compensated cirrhosis treated with interferon alfa , 1997, Hepatology.

[2]  J. Hoofnagle,et al.  Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. , 1997, Gastroenterology.

[3]  Douglas D. Richman,et al.  Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel , 1996 .

[4]  K. O'rourke,et al.  The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men. , 1996, Journal of clinical gastroenterology.

[5]  D. Häussinger,et al.  Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. , 1996, The New England journal of medicine.

[6]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[7]  J. Villeneuve,et al.  Treatment of Chronic Hepatitis B with Interferon: Long Term Follow-Up , 1996 .

[8]  H. Thomas,et al.  Hepatitis B virus precore/core variation and interferon therapy , 1995, Hepatology.

[9]  Stephen J. Williams,et al.  Interferon alfa for chronic active hepatitis B , 1995, The Medical journal of Australia.

[10]  C. Naylor,et al.  Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population. , 1995, Gastroenterology.

[11]  A. Lok,et al.  Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. , 1993, Gastroenterology.

[12]  A. Detsky,et al.  Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B , 1993, Annals of Internal Medicine.

[13]  H. Janssen,et al.  Repeated courses of α-interferon for treatment of chronic hepatitis type B , 1993 .

[14]  B. Scharschmidt,et al.  Hepatitis B in Patients with HIV Infection: Relationship to AIDS and Patient Survival , 1992, Annals of Internal Medicine.

[15]  J. Bartolomé,et al.  Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. , 1992, Journal of hepatology.

[16]  J. Hoofnagle,et al.  Long-term remission of chronic hepatitis B after alpha-interferon therapy. , 1991, Annals of internal medicine.

[17]  O. Strannegard,et al.  Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-alpha and zidovudine. , 1991, The Journal of infectious diseases.

[18]  J. Phair,et al.  Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV-1) infection. , 1990, American journal of public health.

[19]  H. Okamoto,et al.  Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti‐HBe induced spontaneously or with interferon therapy , 1990, Hepatology.

[20]  E. Schiff,et al.  A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B , 1990 .

[21]  J. Hoofnagle.  Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations. , 1990, Journal of hepatology.

[22]  G. Davis,et al.  Interferon Treatment of Viral Hepatitis in Immunocompromised Patients , 1989, Seminars in liver disease.

[23]  B. Donovan,et al.  The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. , 1989, The Journal of infectious diseases.

[24]  S. Banks,et al.  Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial. , 1989, Annals of internal medicine.

[25]  J. Montaner,et al.  Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. , 1989, AIDS.

[26]  P. Scheuer,et al.  Histological improvement after anti-viral treatment for chronic hepatitis B virus infection. , 1989, Journal of hepatology.

[27]  R. Beasley.  Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.

[28]  C. Chu,et al.  The development of cirrhosis in patients with chronic type B hepatitis: A prospective study , 1988, Hepatology.

[29]  J. Nielsen,et al.  The influence of HTLV‐III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers , 1987, Hepatology.